Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals.
about
Pathogenesis of human immunodeficiency virus infectionHerpes simplex virus type 2 seroprevalence in Korea: rapid increase of HSV-2 seroprevalence in the 30s in the southern partPrevalence of HIV infection, sexually transmitted diseases, and hepatitis and related risk behavior in young women living in low-income neighborhoods of northern California.Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2.Genital herpes: review of the epidemic and potential use of type-specific serologyAntiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro.High seroprevalence of herpes simplex virus type 2 infection in French human immunodeficiency virus type 1-infected outpatientsSkin lesions: mirror images of oral lesion infections.Seroprevalence of herpes simplex virus type 1 and type 2 in Turkey.Longitudinal reliability of focus glycoprotein G-based type-specific enzyme immunoassays for detection of herpes simplex virus types 1 and 2 in women.Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population.The Current State of Vaccine Development for Ocular HSV-1 InfectionA perfect storm: crack cocaine, HSV-2, and HIV among non-injecting drug users in New York City.Performance of the Euroline Western blot assay in the detection of herpes simplex virus type 2 antibody in Uganda, China and the USA.Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilizationHuman immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract.Seroprevalence of Herpes Simplex Virus Infection in HIV Coinfected Individuals in Eastern India with Risk Factor Analysis.Serum HSV-1 and 2 IgM in Sexually Transmitted Diseases - More for Screening Less for Diagnosis: An Evaluation of Clinical Manifestation.The expanding realm of heterologous immunity: friend or foe?Diagnostics for herpes simplex virus: is PCR the new gold standard?Herpes simplex virus type 1 morphogenesis and virus-cell interactions: significance of cytoskeleton and methodological aspects.Interactions and management issues in HSV and HIV coinfection.Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1.Explaining racial disparities in HIV/AIDS incidence among women in the U.S.: a systematic reviewPersistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisitionFrequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatmentSexually transmitted infections and use of sexual health services among young Australian women: women's health Australia study.Syringe exchange in Canada: good but not enough to stem the HIV tide.Efficiency of reconstitution of immunoglobulin g from blood specimens dried on filter paper and utility in herpes simplex virus type-specific serology screening.2017 European guidelines for the management of genital herpes.High cumulative incidence of genital herpes amongst HIV-1 seropositive heterosexuals in south London.Herpes simplex virus infections during the decade since the licensure of acyclovir.Association of sexually transmitted diseases and infection with the human immunodeficiency virus: biological cofactors and markers of behavioural interventions.2014 UK national guideline for the management of anogenital herpes.Herpes simplex virus type 2 (HSV-2) genital shedding in HSV-2-/HIV-1-co-infected women receiving effective combination antiretroviral therapy.Development of a time-resolved fluorescence immunoassay for herpes simplex virus type 1 and type 2 IgG antibodies.Enhancement of the anti-herpetic effect of trichosanthin by acyclovir and interferon.Immunity in the female lower genital tract and the impact of HIV infection.Seroepidemiological study of herpes simplex virus type 2 in patients with the acquired immunodeficiency syndrome in the city of Niterói, Rio de Janeiro, Brazil.Herpetic lumbosacral radiculoneuropathy in patients with human immunodeficiency virus infection.
P2860
Q24634681-A8AC5A7F-CEEE-484C-9C01-AF7BA1B0A048Q24647763-6DAEDA75-58D8-48BF-9CFC-F5EC10CAA721Q33727684-EF62800A-E693-44BF-9C95-7D9745FAD35EQ33810615-AAA9BEC8-978C-4EDE-A3DA-5D81D8A1978AQ33975387-201D8909-4563-446D-AFAB-B3AACC4D2C9EQ33992168-F1EC1E52-6483-463B-8988-F5694CBC7387Q34041628-27403B8C-51E5-4DAC-9A65-CCAF27FD24BDQ34521595-C6252B54-D1D9-485D-A581-ED78633ACB70Q34576295-41B0FD7C-984E-4C0D-8C44-A5B1F9F76D86Q34751818-C961EC06-4549-43EE-A9BE-70C1BC73C723Q35562429-45698F5D-9FCC-4FAF-8089-C319CC9EAEA5Q35606611-F5AE1F3C-A019-46A6-A3DF-DB0EAB91A460Q35671191-8B2DD9CD-C506-4F30-9639-7F45F4661405Q35683057-33F65C28-3450-4257-B021-ECA86AC6DB65Q35785221-0024AB89-90BB-456E-9391-9B2E9195C9CAQ35882457-1057A720-0C19-45E8-9D6A-191F9540247CQ36237138-0234570B-2A7A-4825-B393-FD68AAED8CDEQ36283296-69A6AA30-A802-466C-A26C-7977039DF404Q36379481-24BFE35F-A310-4FCF-84A1-FB1438636FFEQ36463219-75092258-A6A5-4033-8697-7F1CECBF214EQ36575899-406BA5B3-5DA1-4CB3-ADDF-5AF59AD547C6Q36777844-CEAC8FAC-7E09-4EF6-9958-E819CD1A10CAQ36799919-C9D70AA2-BC7D-42AA-8601-091704F42EEBQ37190556-43A236C7-057C-44B4-9391-38AC9FB5455DQ37295563-3D43E8E9-2685-4D9C-A9C6-D2E5F87F9751Q37364727-F61E74A7-0F62-47CE-A3CB-EDCB1BAF6DA0Q37876490-D8E16FE4-5572-4517-A2D5-DC9D4F8AFBA4Q39467633-46609BE9-968A-40D7-A07C-2F446B02F6D8Q39662437-4FA18715-995E-4492-B900-4E22F9507976Q40072392-E59425E4-6691-48BC-9EF1-4249EE7F0770Q40587997-6DDC0092-3FCD-4F5B-871E-669914137092Q40782534-0E85F60A-D5C3-4ADD-8398-E3B5606AC0F3Q41107436-CA786873-F64F-4ED6-AAEE-590044B22AADQ41345018-2274336A-1080-4C40-A106-48B6FD33BB44Q41432144-CAB436E5-3542-4EA7-B2AD-C3DFB0B3AF08Q41673194-74333F66-2368-45EF-8CB1-F7316BA9A231Q43610213-9F00C6DA-065B-4832-842F-549DA6DAD1F7Q44212305-06D7DC81-4BC0-4EF9-AFC8-9AE9A3DB370DQ45414197-FDAD8F63-4D2E-4A47-8B18-C2794B3D7512Q45451609-19209C0B-1B7F-496C-9B7C-77A2E24F438C
P2860
Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Herpes simplex virus infection ...... us infection in heterosexuals.
@en
Herpes simplex virus infection ...... us infection in heterosexuals.
@nl
type
label
Herpes simplex virus infection ...... us infection in heterosexuals.
@en
Herpes simplex virus infection ...... us infection in heterosexuals.
@nl
prefLabel
Herpes simplex virus infection ...... us infection in heterosexuals.
@en
Herpes simplex virus infection ...... us infection in heterosexuals.
@nl
P2093
P356
P1476
Herpes simplex virus infection ...... us infection in heterosexuals.
@en
P2093
Campbell CH Jr
Hook EW 3rd
Nahmias AJ
P304
P356
10.1093/INFDIS/165.2.251
P407
P577
1992-02-01T00:00:00Z